Individual cell biology: basis and prospects for a rational cancer chemotherapy.
D000230:Adenocarcinoma / Q000378:metabolism; D001932:Brain Neoplasms / Q000201:enzymology; D001943:Breast Neoplasms / Q000378:metabolism; D002453:Cell Cycle; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003609:Dactinomycin / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005634:Fructose-Bisphosphate Aldolase; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy*; D011379:Prognosis
D004273:DNA, Neoplasm; D007527:Isoenzymes; D003609:Dactinomycin; D003520:Cyclophosphamide; D005634:Fructose-Bisphosphate Aldolase; D005472:Fluorouracil; D008727:Methotrexate